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doi:10.1016/j.ejvsextra.2010.12.001Abstract Foam sclerotherapy is a recognised safe treatment modality for low flow vascular
malformations. Complications are uncommon. We report the complication of vasospasm in
a nineteen year old female with a low flow (venous) malformation of her thenar eminence,
leading to dusky discolouration with pain, coolness, numbness and reduced power following
foam injection. Treatment with intravenous vasodilators enabled full clinical recovery, pre-
venting irreversible complications.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd.
Open access under CC BY-NC-ND license.Introduction
Foam sclerotherapy is a recognised simple, safe treatment
modality for venous malformations (classified as low flow
vascular malformations, LFVM). Complications of percuta-
neous treatment are uncommon. We report the rare
complication of vasospasm causing mottling and dis-
colouration to the forearm and hand post sclerosant
injection and its management.jvs.2010.12.023.
90 119601.
ail.com (M.D.J. Sinclair).
r Vascular Surgery. Published byHistory
A nineteen year old law student attended hospital for
percutaneous foam sclerotherapy to a painful right thenar
eminence LFVM (confirmed by ultrasound (US) scan to have
no arterial signal on spectral Doppler (Fig. 1a), and uniform
high signal on T2W fat-sat sequences with no signal voids).
A 21G butterfly was inserted under topical anaesthesia
and US guidance. A manual blood pressure tourniquet was
applied to the upper forearm (to reduce, but not occlude,
the venous outflow). Contrast was injected to outline the
malformation (moving proximally in keeping with venous
flow). Then, foam sclerosant injected into the malforma-
tion (4 ml 3% sodium tetradecyl sulphate (STD) with 4 ml air
making total of 8 ml foam) under screening control to
displace the contrast. This was aspirated after 5 min andElsevier Ltd. Open access under CC BY-NC-ND license.
Figure 1 a. Injection sclerotherapy of low flow venous malformation. b. Post procedure Doppler US patent arteries.
e8 M.D.J. Sinclair et al.a further 4 ml STD foam injected before applying
a compression bandage.
The patient developed duskiness of her fingers
(10e15 min following the completion of the procedure). The
compression bandage was removed. The duskiness spread to
involve the whole hand, which became painful, cool, numb,
with reduced power. Another 20 min later a clear demarca-
tion from her mid forearm distally to her fingertips (Fig. 2a)
was apparent. Digital pulp capillary refill remained normal.
With unavailable access to finger pressure measurements,
a duplex scan confirmed patent radial/ulnar arteries (with
triphasic flow), patent radial/ulnar venire comitantes at the
wrist and patent metacarpal arteries in the hand (Fig. 1b).
We therefore elected to treat her conservatively with
aspirin 300 mg orally, a transdermal glycerol trinitrate
(GTN) patch (5 mg/24 h), heparin loading dose (5,000 units)
and intravenous (1000 units per hour) infusion and a heated
air blanket (BearHugger Arizant UK Ltd, Wakefield, UK).
Despite these interventions the limb was unchanged over
the following hour.
Intravenous GTN 200 mcg via a cannula in the left arm
immediately improved the mottled appearance of the limb
which completely resolved after 5 min (Fig. 2). The hand
remained swollen and painful with normal capillary refill.
The patient’s arm was elevated in a Bradford sling,
with 24 h intravenous heparin and non-steroidal anti-Figure 2 a. Pre GTN administratiinflammatory treatment. At clinic review 6 weeks post
discharge full clinical recovery was achieved.Discussion
Prolonged vasospasm causing mottling and discolouration of
a limb is a potential complication post foam sclerotherapy.
Foam sclerotherapy (eg STD) is a recognised safe treat-
ment for venous pathologies and often first choice for
LFVM.1,2 The sclerosant is directly injected, using image
guidance, into a vessel or vascular lesion causing endo-
thelial denudation, luminal thrombosis progressing to
fibrosis and long term occlusion.3 Swelling and pain may
occur immediately following the treatment but this settles
within a few weeks to months. Some patients require
repeated sclerotherapy courses.4
Documented complications of foamsclerotherapy include
skin blisters, skin necrosis, transient pain, muscle contrac-
ture, motor or sensory nerve injury (due to swelling or
peripheral nerve damage), superficial cellulitis, deep vein
thrombosis, pulmonary embolus, cardiopulmonary collapse,
transient visual disturbance, ischaemic stroke (right to left
shunt air emboli) and compartment syndrome.2,4
Vasospasm occurs as a direct result of (i) smooth muscle
contraction secondary to the STDand (ii) direct catheterisationon. b. Post GTN administration.
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arterial circulation compounding the venous spasm.
We recommend early administration of IV GTN along
with the conservative measures described above to prevent
potentially irreversible complications. Other vasodilators
and administration routes may be equally efficacious if
there is a failure to respond rapidly to IV GTN, including
intra-arterial GTN, tolazoline papaverine and IV iloprost
(Bayer Schering Pharma AG). Our experience also suggests
that vascular malformations, with the potential for such
complications, should be treated managed in reference
centres where high volume of patients are managed.Conflict of interest/funding
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